A clinical trial to evaluate pregabalin for pain relief after laparoscopic cholecystectomy
Not Applicable
- Conditions
- Health Condition 1: null- ASAPS I or II, 20 - 65 years of either sex, of BMI less than or equal to 30 kg/m2, undergoing elective laparoscopic cholecystectomy under general anaesthesia
- Registration Number
- CTRI/2015/04/005722
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 60
Inclusion Criteria
ASAPS I or II, of BMI less than or equal to 30 kg/m2, undergoing laparoscopic cholecystectomy under general anaesthesia
Exclusion Criteria
impaired kidney or liver functions, history of drug or alcohol abuse, expected difficult airway, history of chronic pain condition or daily intake of analgesics or corticosteroids, consumed gabapentin or pregabalin within 2 weeks prior to surgery, pregnant or lactating, any condition in with the study or rescue drug was contraindicated, ineligible to provide informed consent, any case converted to open cholecystectomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method